Reference: Canadian COVID Care Alliance. (2021). Dispelling the myth of “a pandemic of the unvaccinated.” Retrieved from https://canadiancovidcarealliance.org Summary: The Canadian COVID Care Alliance, comprising over 500 independent healthcare professionals, challenges the narrative that the COVID-19 pandemic is predominantly a crisis among the unvaccinated. The article argues that vaccination rates were high, yet COVID-19 cases […]
Reference: King’s College London. (2021). COVID-19 infections among vaccinated individuals: A rising concern. ZOE COVID Study. Summary: A study from King’s College London revealed that as of July 15, 2021, daily symptomatic COVID-19 cases among vaccinated individuals in the UK averaged 15,537, marking a 40% increase from the previous week. Concurrently, unvaccinated cases decreased by
Reference: Botha, Z. (2023). Observations on health issues post-COVID vaccination: A report. Summary: Dr Zandré Botha reports findings from over fifty patients who experienced significant health issues following the Pfizer and Johnson & Johnson COVID-19 vaccines. Symptoms observed included severe headaches, nerve pain, paranoia, hypertension, blood clots, fatigue, and shortness of breath, among others. Blood
This interview will be broadcast during the live edition of Die GROOT Ontbyt on Wednesday morning, 4 December 2024. It has been a few years since South Africans were advised by the Department of Health to receive the COVID vaccinations. Questions still arise about the research, effectiveness, and side effects among many South Africans. To
Reference: Edeling, H. (2024). Ethical and scientific considerations for Mpox vaccination programs in Africa. SAVIMS. Summary: The article by Dr. Herman Edeling discusses critical ethical and scientific considerations surrounding Mpox vaccination programmes in Africa. It highlights the need for comprehensive clinical assessments and accurate differential diagnoses for blistering skin disorders, emphasising the limitations of current
Reference: World Health Organization. (2024). Mpox. Retrieved from https://www.who.int/news-room/fact-sheets/detail/mpox Summary: Mpox, formerly known as monkeypox, is a viral infection caused by the monkeypox virus, belonging to the Orthopoxvirus genus. The disease presents with symptoms such as fever, rash, headache, muscle pain, and swollen lymph nodes, lasting typically 2–4 weeks. Transmission occurs via close contact with
Reference: Turner, H. (2024, August 23). Virologists blow the whistle: MPOX is actually known side-effect of COVID vax! Hal Turner Radio Show. https://halturnerradioshow.com/index.php/news-selections/world-news/virologists-blow-the-whistle-mpox-is-actually-known-side-effect-of-covid-vax Summary: In a controversial assertion, top virologists, including Dr. Poornima Wagh, have challenged the World Health Organization’s (WHO) narrative surrounding the monkey-pox outbreak. They claim that the symptoms attributed to monkey-pox are
Reference: Wilson, R. (2024, August 22). South African group refutes WHO’s declaration of mpox emergency and warns the public about the risks of the vaccine. The Exposé. Retrieved from https://expose-news.com/2024/08/22/south-african-group-refutes-whos-declaration Summary: The South Africa Vaccine Injury Medico-Legal Study Group (SAVIMS) publicly contested the World Health Organisation’s (WHO) declaration of a global health emergency concerning monkeypox,
Reference: SA Vaccine Injury Medco-Legal Study Group – SAVIMS. (2024, August 18). Statement on proposed emergency roll-out of vaccine program in Africa for monkeypox. Johannesburg, South Africa. Retrieved from www.savims.org.za Summary: The SA Vaccine Injury Medco-Legal Study Group (SAVIMS) has expressed significant concerns regarding the proposed emergency rollout of monkeypox vaccines in Africa, as announced
Reference: World Health Organization. (2024). Mpox global strategic preparedness and response plan. Geneva, Switzerland: Author. Retrieved from https://www.who.int/emergencies/en Summary: The World Health Organization’s Mpox Global Strategic Preparedness and Response Plan (2024) outlines a comprehensive approach to mitigate the resurgence of mpox outbreaks, especially in regions like the Democratic Republic of the Congo (DRC). Following the